Study Highlights the Efficacy of PMC in Suppressing Non-Small Cell Lung Cancer Growth SEOUL, SOUTH KOREA, January 23, 2026 ...

Bufadienolides, a class of cardiotonic steroids primarily isolated from toad venom, have emerged as potent agents in the field of cancer therapeutics. Their bioactivity is largely attributed to their ...

Capsaicin, the bioactive compound responsible for the characteristic spiciness of chilli peppers, has attracted considerable attention for its anticancer properties. In various cancer cell types, ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced that the China National Intellectual Property ...

The field of regulated cell death has undergone a transformative shift with the discovery of novel modalities beyond apoptosis, such as ferroptosis, which ...

Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances achieved in recent years, resistance to available treatments remains one of the ...

Scientists at NYU Abu Dhabi have developed an innovative use for nanotechnology in the field of cancer research. Their multidisciplinary team, led by Biology Associate Professor Mazin Magzoub, is ...

The China National Intellectual Property Administration approved the patent covering Hoth’s HT-KIT technology, which is designed to induce apoptosis (programmed cell death) in cancer cells by ...

Albizzia julibrissin is a widely distributed plant in China. Its dried stem bark has been used in traditional oriental medicine to treat insomnia, diuresis, sthenia, ascaricide, and confusion.

Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate, becoming essentially a zombie cell.